A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

The APOE gene encoding the Apolipoprotein E protein is the single most significant genetic risk factor for late‐onset Alzheimer's disease. The APOE4 genotype confers a significantly increased risk relative to the other two common genotypes APOE3 and APOE2. Intriguingly, APOE4 has been associated with neuropathological and cognitive deficits in the absence of Alzheimer's disease‐related amyloid or tau pathology. Here, we review the extensive literature surrounding the impact of APOE genotype on central nervous system dysfunction, focussing on preclinical model systems and comparison of APOE3 and APOE4, given the low global prevalence of APOE2. A multi‐hit hypothesis is proposed to explain how APOE4 shifts cerebral physiology towards pathophysiology through interconnected hits. These hits include the following: neurodegeneration, neurovascular dysfunction, neuroinflammation, oxidative stress, endosomal trafficking impairments, lipid and cellular metabolism disruption, impaired calcium homeostasis and altered transcriptional regulation. The hits, individually and in combination, leave the APOE4 brain in a vulnerable state where further cumulative insults will exacerbate degeneration and lead to cognitive deficits in the absence of Alzheimer's disease pathology and also a state in which such pathology may more easily take hold. We conclude that current evidence supports an APOE4 multi‐hit hypothesis, which contributes to an APOE4 pathophysiological state. We highlight key areas where further study is required to elucidate the complex interplay between these individual mechanisms and downstream consequences, helping to frame the current landscape of existing APOE‐centric literature.

[1]  Xiaochun Chen,et al.  APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline , 2021, Translational Psychiatry.

[2]  Rosemary J. Jackson,et al.  Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer’s disease , 2021, Nature Aging.

[3]  G. Gouras,et al.  Astrocytic and Neuronal Apolipoprotein E Isoforms Differentially Affect Neuronal Excitability , 2021, Frontiers in Neuroscience.

[4]  G. Rebeck,et al.  High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice , 2021, Journal of Neuroinflammation.

[5]  D. Bennett,et al.  Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease , 2021, Alzheimer's research & therapy.

[6]  Xiaochun Chen,et al.  ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment. , 2021, Journal of psychiatric research.

[7]  David A. Brafman,et al.  Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids , 2021, Acta Neuropathologica.

[8]  L. Tsai,et al.  APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation , 2021, Stem cell reports.

[9]  J. Tulloch,et al.  Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease , 2021, European journal of neurology.

[10]  A. Gavin,et al.  APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes , 2021, bioRxiv.

[11]  R. Hammer,et al.  NHE6-Depletion Corrects ApoE4-Mediated Synaptic Impairments and Reduces Amyloid Plaque Load , 2021, bioRxiv.

[12]  R. Jacobs,et al.  Author Correction: APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β , 2021, Nature Aging.

[13]  Pu Wang,et al.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau , 2021, International journal of molecular sciences.

[14]  S. King,et al.  APOE4 genotype increases neuronal calcium signals and decreases pial arteriole responsivity and vasomotion in visual cortex of awake mice , 2021 .

[15]  D. Bennett,et al.  Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease , 2021, Nature Neuroscience.

[16]  Ying Han,et al.  Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population , 2021, Alzheimer's research & therapy.

[17]  G. Rebeck,et al.  Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation , 2021, Glia.

[18]  Keqiang He,et al.  Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory , 2021, Neuron.

[19]  G. Gouras,et al.  APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis , 2020, The Journal of Neuroscience.

[20]  David A. Brafman,et al.  APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids , 2020, Nature Communications.

[21]  L. Tsai,et al.  PICALM Rescues Endocytic Defects Caused by the Alzheimer's Disease Risk Factor APOE4. , 2020, Cell reports.

[22]  C. Howarth,et al.  More than just summed neuronal activity: how multiple cell types shape the BOLD response , 2020, Philosophical Transactions of the Royal Society B.

[23]  G. Rebeck,et al.  ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease , 2020, International journal of molecular sciences.

[24]  Ching-On Wong Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes , 2020, International journal of molecular sciences.

[25]  Melanie A. Huntley,et al.  Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation , 2020, Cell reports.

[26]  C. Finch,et al.  APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease , 2020, Frontiers in Aging Neuroscience.

[27]  G. Perea,et al.  Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice , 2020, Molecular Neurodegeneration.

[28]  Matheus B. Victor,et al.  Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes , 2020, Nature Medicine.

[29]  M. Sabbagh,et al.  Effect of ApoE isoforms on mitochondria in Alzheimer disease , 2020, Neurology.

[30]  R. Lipton,et al.  APOE ε4 and the influence of sex, age, vascular risk factors, and ethnicity on cognitive decline. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  D. Wilcock,et al.  The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease , 2020, Frontiers in Immunology.

[32]  A. Fagan,et al.  APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.

[33]  Y. Asmann,et al.  Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways , 2020, Neuron.

[34]  J. Grutzendler,et al.  TREM2: Modulator of Lipid Metabolism in Microglia , 2020, Neuron.

[35]  Tzong-Shiue Yu,et al.  Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury , 2020, PloS one.

[36]  Xianlin Han,et al.  Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome , 2020, Nature Communications.

[37]  J. Rusted,et al.  Mid age APOE ε4 carriers show memory-related functional differences and disrupted structure-function relationships in hippocampal regions , 2020, Scientific Reports.

[38]  Juan Maldonado Weng,et al.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How , 2020, Neurobiology of Disease.

[39]  J. Arbonés-Mainar,et al.  Beyond the CNS: The many peripheral roles of APOE , 2020, Neurobiology of Disease.

[40]  W. Banks,et al.  ApoE and cerebral insulin: Trafficking, receptors, and resistance , 2020, Neurobiology of Disease.

[41]  Matthew S. Gentry,et al.  APOE alters glucose flux through central carbon pathways in astrocytes , 2020, Neurobiology of Disease.

[42]  G. Rebeck,et al.  APOE in the normal brain , 2020, Neurobiology of Disease.

[43]  N. Chandel,et al.  Mitochondrial TCA cycle metabolites control physiology and disease , 2020, Nature Communications.

[44]  Steve Lianoglou,et al.  TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.

[45]  H. Chui,et al.  ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes , 2019, The Journal of Neuroscience.

[46]  H. Bian,et al.  Carnosic Acid Reverses the Inhibition of ApoE4 on Cell Surface Level of ApoER2 and Reelin Signaling Pathway. , 2019, Journal of Alzheimer's disease : JAD.

[47]  C. Finch,et al.  The Exposome in Human Evolution: From Dust to Diesel , 2019, The Quarterly Review of Biology.

[48]  Franz Resch,et al.  [Early Life Stress]. , 2019, Praxis der Kinderpsychologie und Kinderpsychiatrie.

[49]  Hailan Yao,et al.  Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities , 2019, Front. Cell. Neurosci..

[50]  Dean P. Jones,et al.  Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE ε3, but not APOE ε4, targeted replacement mice , 2019, Neurobiology of Aging.

[51]  G. Cenini,et al.  Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update , 2019, Front. Pharmacol..

[52]  G. Petsko,et al.  ENDOSOMAL TRAFFIC JAMS REPRESENT A PATHOGENIC HUB AND THERAPEUTIC TARGET IN ALZHEIMER’S DISEASE , 2019, Alzheimer's & Dementia.

[53]  Yadong Huang,et al.  Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease , 2019, Molecular Neurodegeneration.

[54]  Youssra K Al-Hilaly,et al.  The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease , 2019, Journal of molecular biology.

[55]  N. V. van Nuland,et al.  Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation , 2019, FEBS letters.

[56]  Rosemary J. Jackson,et al.  Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype , 2019, Acta Neuropathologica Communications.

[57]  M. Glatzel,et al.  Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro , 2019, Front. Cell. Neurosci..

[58]  L. Frank,et al.  Early Hippocampal Sharp-Wave Ripple Deficits Predict Later Learning and Memory Impairments in an Alzheimer’s Disease Mouse Model , 2019, bioRxiv.

[59]  R. Kukreti,et al.  Oxidative Stress: A Key Modulator in Neurodegenerative Diseases , 2019, Molecules.

[60]  K. Gibas,et al.  APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study , 2019, Alzheimer's & dementia.

[61]  A. Fagan,et al.  Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network , 2019, Neurobiology of Aging.

[62]  Brandon C Farmer,et al.  Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation , 2019, Cells.

[63]  C. Weber,et al.  ApoE attenuates unresolvable inflammation by complex formation with activated C1q , 2019, Nature Medicine.

[64]  N. Fitz,et al.  The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives , 2018, International journal of molecular sciences.

[65]  A. Fagan,et al.  Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.

[66]  E. Fraenkel,et al.  APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice , 2018, Scientific Reports.

[67]  Rosemary J. Jackson,et al.  Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease , 2018, Neuropathology and applied neurobiology.

[68]  P. Mathews,et al.  Apolipoprotein E4 genotype compromises brain exosome production , 2018, Brain : a journal of neurology.

[69]  T. Südhof,et al.  Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer’s Disease Risk , 2018, bioRxiv.

[70]  J. Mandelblatt,et al.  Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy , 2018, Neurotoxicity Research.

[71]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[72]  Henning U Voss,et al.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function , 2018, Nature Communications.

[73]  Tuan Leng Tay,et al.  Unique microglia recovery population revealed by single-cell RNAseq following neurodegeneration , 2018, Acta neuropathologica communications.

[74]  D. Holtzman,et al.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight , 2018, Nature Reviews Immunology.

[75]  Tzong-Shiue Yu,et al.  ApoE Regulates the Development of Adult Newborn Hippocampal Neurons , 2018, eNeuro.

[76]  R. Rao,et al.  Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH , 2018, Proceedings of the National Academy of Sciences.

[77]  Elizabeta Gjoneska,et al.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.

[78]  S. Villapol,et al.  Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury , 2018, Molecular Neurodegeneration.

[79]  Daniel R. Dries,et al.  APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[80]  G. Bu,et al.  Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease , 2018, Biological Psychiatry.

[81]  A. Saghatelian,et al.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis , 2018, The Journal of Biological Chemistry.

[82]  Yadong Huang,et al.  Gain of toxic Apolipoprotein E4 effects in Human iPSC-Derived Neurons Is Ameliorated by a Small-Molecule Structure Corrector , 2018, Nature Medicine.

[83]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[84]  M. Cookson,et al.  The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo , 2017, Front. Neurosci..

[85]  J. Raber,et al.  Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[86]  Geoffrey M. Barrett,et al.  Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology , 2017, Nature Communications.

[87]  M. Welte,et al.  Lipid droplet functions beyond energy storage. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[88]  C. Iadecola The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.

[89]  G. Bu,et al.  Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes , 2017, Neuron.

[90]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[91]  Nick C Fox,et al.  ApoE influences regional white-matter axonal density loss in Alzheimer's disease , 2017, Neurobiology of Aging.

[92]  F. Calon,et al.  Docosahexaenoic acid prevents cognitive deficits in human apolipoprotein E epsilon 4-targeted replacement mice , 2017, Neurobiology of Aging.

[93]  J. Schug,et al.  Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury , 2017, Neurobiology of Disease.

[94]  L. Farde,et al.  Differential Effect of APOE Alleles on Brain Glucose Metabolism in Targeted Replacement Mice: An [18F]FDG-μPET Study , 2017, Journal of Alzheimer's disease reports.

[95]  Jiong Shi,et al.  Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene , 2017, CNS neuroscience & therapeutics.

[96]  S. Villapol,et al.  Reduced cortical excitatory synapse number in APOE4 mice is associated with increased calcineurin activity , 2017, Neuroreport.

[97]  Gokula Mohan,et al.  Neuroinflammation pathways: a general review , 2017, The International journal of neuroscience.

[98]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[99]  Carl Frieden,et al.  A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain–domain interactions , 2017, Proceedings of the National Academy of Sciences.

[100]  J. Herz,et al.  ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease , 2017, Trends in Endocrinology & Metabolism.

[101]  P. Ladd,et al.  Faculty Opinions recommendation of Apoe2, apoe3, and apoe4 differentially stimulate APP transcription and aβ secretion. , 2017 .

[102]  William Charles Kreisl,et al.  Neuroinflammation in Neurodegenerative Disorders—a Review , 2017, Current Neurology and Neuroscience Reports.

[103]  G. Rebeck,et al.  The role of APOE on lipid homeostasis and inflammation in normal brains , 2017, Journal of Lipid Research.

[104]  N. Maeda,et al.  Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice , 2017, Molecular Neurodegeneration.

[105]  S. Salim,et al.  Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[106]  R. Rimondini,et al.  Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis , 2016, Journal of Alzheimer's disease : JAD.

[107]  G. Sobue,et al.  Exosome secretion is a key pathway for clearance of pathological TDP-43. , 2016, Brain : a journal of neurology.

[108]  P. Calder Docosahexaenoic Acid , 2016, Annals of Nutrition and Metabolism.

[109]  B. Cosquer,et al.  APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input , 2016, The Journal of Neuroscience.

[110]  G. Rebeck,et al.  Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid , 2016, Journal of Neuropathology and Experimental Neurology.

[111]  Luca Marchetti,et al.  Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s disease , 2016, Scientific Reports.

[112]  J. Raber,et al.  Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species , 2016, Journal of neurochemistry.

[113]  G. Rimbach,et al.  APOE genotype and stress response - a mini review , 2016, Lipids in Health and Disease.

[114]  J. Diedrich,et al.  HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective. , 2016, Journal of the American Chemical Society.

[115]  Jing Zhang,et al.  Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice , 2016, Molecular Neurodegeneration.

[116]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[117]  S. Gratteri,et al.  Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease , 2016, BioMed research international.

[118]  C. Brayne,et al.  Microglial immunophenotype in dementia with Alzheimer’s pathology , 2016, Journal of Neuroinflammation.

[119]  S. Dumanis,et al.  Identification and modification of amyloid-independent phenotypes of APOE4 mice , 2016, Experimental Neurology.

[120]  R. Mahley Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[121]  Valerio Zerbi,et al.  A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.

[122]  Yadong Huang,et al.  Enhancing GABA Signaling during Middle Adulthood Prevents Age-Dependent GABAergic Interneuron Decline and Learning and Memory Deficits in ApoE4 Mice , 2016, The Journal of Neuroscience.

[123]  Guojun Bu,et al.  The role of APOE in cerebrovascular dysfunction , 2016, Acta Neuropathologica.

[124]  S. Schmid,et al.  Endocytic pathways and endosomal trafficking: a primer , 2016, Wiener Medizinische Wochenschrift.

[125]  D. Bredesen,et al.  Direct Transcriptional Effects of Apolipoprotein E , 2016, The Journal of Neuroscience.

[126]  Wei Zhang,et al.  Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[127]  W. Funkhouser,et al.  APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction , 2015, PLoS biology.

[128]  Matthew C Kiernan,et al.  TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. , 2015, Brain : a journal of neurology.

[129]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[130]  M. Farzan,et al.  The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.

[131]  J. Zhong,et al.  Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury , 2015, Neuroscience.

[132]  M. Hutchison,et al.  The role of apolipoprotein E episilon (ɛ)-4 allele on outcome following traumatic brain injury: A systematic review , 2015, Brain injury.

[133]  E. Gratton,et al.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.

[134]  J. Domingo,et al.  Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model , 2015, Physiology & Behavior.

[135]  M. Cusimano,et al.  Association of the APOE-ε4 allele with outcome of traumatic brain injury in children and youth: a meta-analysis and meta-regression , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[136]  Pinal N. Kanabar,et al.  APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective , 2015, Journal of neurochemistry.

[137]  M. LaDu,et al.  APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice , 2015, Molecular Neurodegeneration.

[138]  Huaxi Xu,et al.  Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice , 2015, Molecular Neurodegeneration.

[139]  K. Katayama,et al.  Reelin receptors ApoER2 and VLDLR are expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex , 2015, The Journal of comparative neurology.

[140]  T. Montine,et al.  APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production , 2015, Glia.

[141]  F. Calon,et al.  Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[142]  R. Mahley,et al.  Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases , 2014, Neurobiology of Disease.

[143]  Guoqiang Bi,et al.  Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain. , 2014, International Journal of Neuropsychopharmacology.

[144]  Valerio Zerbi,et al.  Resting-State Functional Connectivity Changes in Aging apoE4 and apoE-KO Mice , 2014, The Journal of Neuroscience.

[145]  A. Gillespie,et al.  Apolipoprotein E4 Produced in GABAergic Interneurons Causes Learning and Memory Deficits in Mice , 2014, Journal of Neuroscience.

[146]  C. Low,et al.  Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice , 2014, Scientific Reports.

[147]  S. D. Moore,et al.  Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice , 2014, Neurobiology of Aging.

[148]  J. Herz,et al.  More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration , 2014, Neuron.

[149]  P. Blackshear,et al.  APOε4 is associated with enhanced in vivo innate immune responses in human subjects. , 2014, The Journal of allergy and clinical immunology.

[150]  G. Rebeck,et al.  Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease , 2014, PloS one.

[151]  D. Attwell,et al.  Capillary pericytes regulate cerebral blood flow in health and disease , 2014, Nature.

[152]  S. Coons,et al.  Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice. , 2014, Current Alzheimer research.

[153]  Guojun Bu,et al.  ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners? , 2014, Neuron.

[154]  H. Meziane,et al.  Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: Pathophysiological relevance for Alzheimer's disease? , 2014, Brain Research.

[155]  Chunjiang Yu,et al.  ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro , 2013, ASN neuro.

[156]  D. Bredesen,et al.  Neuroprotective Sirtuin ratio reversed by ApoE4 , 2013, Proceedings of the National Academy of Sciences.

[157]  T. Montine,et al.  Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. , 2013, JAMA neurology.

[158]  D. Holtzman,et al.  In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis , 2013, Molecular Neurodegeneration.

[159]  Yadong Huang,et al.  Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development , 2013, PloS one.

[160]  K. Rosenblum,et al.  ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice , 2013, Neurobiology of Aging.

[161]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[162]  J. Raber,et al.  ApoE isoform modulates effects of cranial 56Fe irradiation on spatial learning and memory in the water maze , 2013, Behavioural Brain Research.

[163]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice , 2012, PloS one.

[164]  W. Jagust,et al.  Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.

[165]  R. Mahley,et al.  Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.

[166]  L. Westlye,et al.  Effects of APOE on brain white matter microstructure in healthy adults , 2012, Neurology.

[167]  Hong Yang,et al.  Apolipoprotein E4 Is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway , 2012, PloS one.

[168]  R. Carare,et al.  Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele , 2012, PloS one.

[169]  Steven Hou,et al.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. , 2012, Brain : a journal of neurology.

[170]  A. Jaeschke,et al.  Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress* , 2012, The Journal of Biological Chemistry.

[171]  Robert V Farese,et al.  Lipid droplets and cellular lipid metabolism. , 2012, Annual review of biochemistry.

[172]  S. Dumanis,et al.  APOE genotype alters glial activation and loss of synaptic markers in mice , 2012, Glia.

[173]  Clare E. Mackay,et al.  The effects of APOE-ε4 on the BOLD response , 2012, Neurobiology of Aging.

[174]  Gui-rong Zhang,et al.  Development and Stem Cells Research Article , 2022 .

[175]  C. Brayne,et al.  Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype , 2011, Neurobiology of Aging.

[176]  Klaus P. Ebmeier,et al.  The APOE ɛ4 allele modulates brain white matter integrity in healthy adults , 2011, Molecular Psychiatry.

[177]  M. Fessler,et al.  Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.

[178]  Ralph A. Nixon,et al.  Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.

[179]  A. von Eckardstein,et al.  Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[180]  P. Grammas,et al.  Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[181]  Scott A. Peterson,et al.  Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors* , 2011, The Journal of Biological Chemistry.

[182]  S. D. Han,et al.  The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations , 2011, International journal of Alzheimer's disease.

[183]  Paul M. Matthews,et al.  Differential effects of the APOE genotype on brain function across the lifespan , 2011, NeuroImage.

[184]  M. Mattson,et al.  Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease , 2010, Neural plasticity.

[185]  R. Mahley,et al.  Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[186]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.

[187]  L. Mucke,et al.  Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. , 2010, The American journal of pathology.

[188]  H. Vinters,et al.  Synapse loss in dementias , 2010, Journal of neuroscience research.

[189]  V. Mathura,et al.  Apolipoprotein E genotype and oxidative stress response to traumatic brain injury , 2010, Neuroscience.

[190]  J. Herz,et al.  ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling , 2010, Proceedings of the National Academy of Sciences.

[191]  D. Hui,et al.  Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms. , 2010, The Biochemical journal.

[192]  R. Mahley,et al.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. , 2009, Cell stem cell.

[193]  E. Weeber,et al.  ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo , 2009, The Journal of Neuroscience.

[194]  Zhao Wang,et al.  ApoE 4 reduces the expression of Aβ degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons , 2009, Neuroscience Letters.

[195]  I. Mikhailenko,et al.  Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation , 2009, Journal of Neuroimmunology.

[196]  Carol A. Colton,et al.  APOE genotype-specific differences in the innate immune response , 2009, Neurobiology of Aging.

[197]  M. Michikawa,et al.  Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells , 2009, Molecular Neurodegeneration.

[198]  M. Michikawa,et al.  Mechanism underlying apolipoprotein E (ApoE) isoform‐dependent lipid efflux from neural cells in culture , 2009, Journal of neuroscience research.

[199]  K. Weisgraber,et al.  Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function* , 2009, The Journal of Biological Chemistry.

[200]  R. Ph Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. , 2009 .

[201]  M. Puzianowska-Kuźnicka,et al.  The ER and ageing II: Calcium homeostasis , 2009, Ageing Research Reviews.

[202]  Carl W. Cotman,et al.  Exercise improves cognition and hippocampal plasticity in APOE ε4 mice , 2009, Alzheimer's & Dementia.

[203]  E. Weeber,et al.  ApoE isoform-dependent changes in hippocampal synaptic function , 2009, Molecular Neurodegeneration.

[204]  A. D. de Craen,et al.  APOE genotype modulates the effect of serum calcium levels on cognitive function in old age , 2009, Neurology.

[205]  M. Burns,et al.  Low‐density lipoprotein receptors regulate microglial inflammation through c‐Jun N‐terminal kinase , 2009, Glia.

[206]  M. Pangalos,et al.  Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels , 2008, The Journal of Neuroscience.

[207]  Z. Rahimi,et al.  Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. , 2008, Clinical biochemistry.

[208]  Mark W. Bondi,et al.  Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis , 2008, Alzheimer's & Dementia.

[209]  A. Roses,et al.  Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons , 2008, Proceedings of the National Academy of Sciences.

[210]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[211]  Nicolas Cherbuin,et al.  Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.

[212]  T. Foster,et al.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain , 2007, Aging cell.

[213]  S. Fujita,et al.  Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons , 2007, Molecular Neurodegeneration.

[214]  A. Minihane,et al.  Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages. , 2007, The British journal of nutrition.

[215]  T. Montine,et al.  Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity , 2006, Journal of Neuroinflammation.

[216]  K. Weisgraber,et al.  Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.

[217]  David Walker,et al.  Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.

[218]  T. Montine,et al.  Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice , 2006 .

[219]  T. Montine,et al.  Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[220]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[221]  O. Gureje,et al.  APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians , 2006 .

[222]  R. Elkon,et al.  Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade , 2005, Neurobiology of Disease.

[223]  A. LeBlanc,et al.  The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. , 2005, Current Alzheimer research.

[224]  John W. Ferkany,et al.  Receptor Binding , 2005 .

[225]  D. Hui,et al.  The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. , 2005, Biochemistry.

[226]  D. C. Harris,et al.  Multiple pathways of apolipoprotein E signaling in primary neurons , 2005, Journal of neurochemistry.

[227]  M. Vitek,et al.  A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.

[228]  S. D. Moore,et al.  Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology , 2005, Neurobiology of Disease.

[229]  D. Schmechel,et al.  Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.

[230]  D. Grainger,et al.  Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1 , 2004, The Journal of Immunology.

[231]  R. Mahley,et al.  Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase , 2004, Journal of Biological Chemistry.

[232]  D. Butterfield,et al.  Effects of apolipoprotein E on the human immunodeficiency virus protein tat in neuronal cultures and synaptosomes , 2004, Journal of neuroscience research.

[233]  B. Hyman,et al.  Apolipoprotein E Receptors Mediate Neurite Outgrowth through Activation of p44/42 Mitogen-activated Protein Kinase in Primary Neurons* , 2004, Journal of Biological Chemistry.

[234]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[235]  Tony Wyss-Coray,et al.  Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.

[236]  W. Strittmatter,et al.  APOE genotype-specific differences in human and mouse macrophage nitric oxide production , 2004, Journal of Neuroimmunology.

[237]  S. Paul,et al.  A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes , 2004, Journal of neurochemistry.

[238]  J. Sweatt,et al.  Receptor Clustering Is Involved in Reelin Signaling , 2004, Molecular and Cellular Biology.

[239]  R. Mahley,et al.  Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells , 2004, Journal of Biological Chemistry.

[240]  B. Hyman,et al.  ApoE isoforms affect neuronal N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes , 2003, Neuroscience.

[241]  D. Holtzman,et al.  Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients , 2003, Neuroscience.

[242]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[243]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[244]  L. Mucke,et al.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[245]  D. Ashline,et al.  Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. , 2002, Free radical biology & medicine.

[246]  C. Colton,et al.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.

[247]  W. Schneider,et al.  The PX‐domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor , 2002, The EMBO journal.

[248]  C. Colton,et al.  Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.

[249]  M. Donowitz,et al.  Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. , 2002, American journal of physiology. Cell physiology.

[250]  J. Gilbert,et al.  Defective neuronal sprouting by human apolipoprotein E4 is a gain‐of‐negative function , 2002, Journal of neuroscience research.

[251]  D. Lala Liver X Receptors , 2002 .

[252]  E. Masliah,et al.  Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis , 2002, Journal of neuroscience research.

[253]  Xianlin Han,et al.  Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice , 2001, Neurochemistry International.

[254]  Robert V Farese,et al.  Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[255]  R. Mahley,et al.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[256]  K. Horsburgh,et al.  Alterations in ApoE and ApoJ in Relation to Degeneration and Regeneration in a Mouse Model of Entorhinal Cortex Lesion , 2001, Experimental Neurology.

[257]  O Almkvist,et al.  Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.

[258]  D. Levy,et al.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. , 2001, Atherosclerosis.

[259]  T. Ogihara,et al.  Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway* , 2001, The Journal of Biological Chemistry.

[260]  Johnm . Taylor,et al.  Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain , 2001, The Journal of Neuroscience.

[261]  S. Pizzo,et al.  Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides , 2001, Experimental Neurology.

[262]  E. Boerwinkle,et al.  Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. , 2000, Genome research.

[263]  J. Vaupel,et al.  Estimation of apolipoprotein E genotype‐specific relative mortality risks from the distribution of genotypes in centenarians and middle‐aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene” , 2000, Genetic epidemiology.

[264]  D. Breuillé,et al.  High-fat diet. , 2000 .

[265]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[266]  M. Stewart,et al.  Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human Apolipoprotein E4 transgenic mice , 2000, Neuroscience.

[267]  M. Mattson,et al.  A Mechanism for the Neuroprotective Effect of Apolipoprotein E , 2000, Journal of neurochemistry.

[268]  L. Mucke,et al.  Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease , 2000, Neuroscience.

[269]  Q. Fan,et al.  Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture , 2000, Journal of neurochemistry.

[270]  Y. Christen,et al.  Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain , 2000, Neurobiology of Disease.

[271]  M. Mattson,et al.  Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity , 1999, The Journal of Neuroscience.

[272]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[273]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[274]  R. Mahley,et al.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.

[275]  J. Gilbert,et al.  Differential neurotrophic effects of apolipoprotein E in aged transgenic mice , 1999, Neuroscience Letters.

[276]  E. Stadtman,et al.  Methionine residues may protect proteins from critical oxidative damage , 1999, Mechanisms of Ageing and Development.

[277]  J. Gilbert,et al.  Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.

[278]  A. Delacourte,et al.  Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele , 1998, Neuroscience Letters.

[279]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[280]  H Okada,et al.  Altered glucose metabolism in the hippocampal head in memory impairment , 1998, Neurology.

[281]  M. Graeber,et al.  Microglial Activation in Alzheimer Disease: Association with APOE Genotype , 1998, Brain pathology.

[282]  J. Haines,et al.  Effects of Age and Ethnicity on the Link Between APOE ∊4 and Alzheimer Disease—Reply , 1998 .

[283]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[284]  E. Gruenstein,et al.  Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide , 1997, Journal of cellular physiology.

[285]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[286]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[287]  M. Nakai,et al.  Expression of apolipoprotein E mRNA in rat microglia , 1996, Neuroscience Letters.

[288]  T. Montine,et al.  Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation , 1996, Journal of neuropathology and experimental neurology.

[289]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[290]  J C Mazziotta,et al.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.

[291]  D. Agard,et al.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .

[292]  T. Hayek,et al.  Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. , 1994, Biochemical and biophysical research communications.

[293]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[294]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[295]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[296]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[297]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[298]  R. Mahley,et al.  Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state , 1988, The Journal of cell biology.

[299]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[300]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[301]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[302]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[303]  J. Breslow,et al.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.

[304]  A. Bruni,et al.  The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers. , 2016, Journal of Alzheimer's disease : JAD.

[305]  Liqin Zhao,et al.  Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. , 2015, Journal of Alzheimer's disease : JAD.

[306]  Emily H. Trittschuh,et al.  Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. , 2015, Journal of Alzheimer's disease : JAD.

[307]  R. T. Alexander,et al.  Traditional and emerging roles for the SLC9 Na+/H+ exchangers , 2013, Pflügers Archiv - European Journal of Physiology.

[308]  Suzanne Craft,et al.  Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[309]  R. Rimondini,et al.  Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice. , 2012, Journal of Alzheimer's disease : JAD.

[310]  Men-Tzung Lo,et al.  Impaired Cerebral , 2012 .

[311]  S. Coons,et al.  Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. , 2011, Journal of Alzheimer's disease : JAD.

[312]  Susan M. Resnick,et al.  APOE ε 4 GENOTYPE AND LONGITUDINAL CHANGES IN CEREBRAL BLOOD FLOW IN NORMAL AGING , 2010 .

[313]  S. Caplan,et al.  The early endosome: a busy sorting station for proteins at the crossroads. , 2010, Histology and histopathology.

[314]  Y. Y. Tam,et al.  The Endocytic Pathway , 2009 .

[315]  Gerald Rimbach,et al.  Impact of apoE genotype on oxidative stress, inflammation and disease risk. , 2008, Molecular nutrition & food research.

[316]  K. Weisgraber,et al.  Apolipoprotein E4 Forms a Molten Globule A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE* , 2002 .

[317]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[318]  G. Siest,et al.  Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. , 2000, Free radical biology & medicine.

[319]  K. Weisgraber Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[320]  D. Russell,et al.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.